The State Food and Drug Administration (SFDA) issued the No.1 Drug Clinical Trial Institution Qualification Announcement on February 3, 2005. The verified 17 medical institutions are: 302 Hospital of Chinese PLA, 304 Hospital of Chinese PLA, 306 Hospital of Chinese PLA, Shanghai Changhai Hospital, Shanghai Changzheng Hospital, Guangzhou General Hospital of Guangzhou Military Area Command of PLA, Wuhan General Hospital of Guangzhou Military Area Command of PLA, Nanfang Hospital of the Southern Medical University, Zhujiang Hospital of the Southern Medical University, First Affiliated Hospital of the Fourth Military Medical University of Chinese PLA, TangDu Hospital of the Fourth Military Medical University of Chinese PLA, Lanzhou General Hospital of Lanzhou Military Area Command of PLA, General hospital of Jinan Military Area Command of PLA, Fuzhou General Hospital of Nanjing Military Area Command of PLA, General hospital of Shenyang Military Area Command of PLA, 254 Hospital of Chinese PLA, 210 Hospital of Chinese PLA.